Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 204783
                    [Title] => Drugs return as trypanosomiasis reemerges
                    [Summary] => The approval of the cosmetic formulation of eflornithine encouraged the reintroductions of its intravenous formulation and of nifurtimox, both used to treat African trypanosomiasis it was reported at an international conference on emerging infectious diseases sponsored by the Centers for Disease  Control and Prevention. The production of both drugs had been halted when sleeping sickness was almost eradicated in the 1960s and surveillance and treatment programs were dismantled during subsequent civil unrest and wars in central Africa.
                    [DatePublished] => 2003-05-04 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 143610
                    [Title] => The Zuellig Foundation Donates P.5-M Measles Vaccines for DOH
                    [Summary] => Health Secretary Manuel Dayrit (4th from left) shakes the hand of Reiner Gloor, board member of Zuellig Foundation, after Gloor turned over 2,000 measles vaccines to the Department of Health to be used in its continuing campaign to eradicate measles in the country.



Aventis Pasteur, Merck Sharp & Dohme Phils., GlaxoSmithKline and Zuellig Pharma donated the vaccines through the Zuellig Foundation as their contribution to the fight against the disease.



                    [DatePublished] => 2001-12-14 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

AVENTIS PASTEUR

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 204783
                    [Title] => Drugs return as trypanosomiasis reemerges
                    [Summary] => The approval of the cosmetic formulation of eflornithine encouraged the reintroductions of its intravenous formulation and of nifurtimox, both used to treat African trypanosomiasis it was reported at an international conference on emerging infectious diseases sponsored by the Centers for Disease  Control and Prevention. The production of both drugs had been halted when sleeping sickness was almost eradicated in the 1960s and surveillance and treatment programs were dismantled during subsequent civil unrest and wars in central Africa.
                    [DatePublished] => 2003-05-04 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 143610
                    [Title] => The Zuellig Foundation Donates P.5-M Measles Vaccines for DOH
                    [Summary] => Health Secretary Manuel Dayrit (4th from left) shakes the hand of Reiner Gloor, board member of Zuellig Foundation, after Gloor turned over 2,000 measles vaccines to the Department of Health to be used in its continuing campaign to eradicate measles in the country.



Aventis Pasteur, Merck Sharp & Dohme Phils., GlaxoSmithKline and Zuellig Pharma donated the vaccines through the Zuellig Foundation as their contribution to the fight against the disease.



                    [DatePublished] => 2001-12-14 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest

Drugs return as trypanosomiasis reemerges

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | May 4, 2003 - 12:00am

The approval of the cosmetic formulation of eflornithine encouraged the reintroductions of its intravenous formulation and of nifurtimox, both used to treat African trypanosomiasis it was reported at an international...

Opinion

The Zuellig Foundation Donates P.5-M Measles Vaccines for DOH

December 14, 2001 - 12:00am

Health Secretary Manuel Dayrit (4th from left) shakes the hand of Reiner Gloor, board member of Zuellig Foundation, after Gloor turned over 2,000 measles vaccines to the Department of Health to be used in its continuing...

Health And Family